Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Davies, N"'
Autor:
Emeh P; The Swedish Drug Delivery Center, Department of Pharmacy, Uppsala University, BMC P.O. Box 580, Uppsala 751 23, Sweden., Breitholtz K; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg 431 83, Sweden., Berg S; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg 431 83, Sweden., Vedin C; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg 431 83, Sweden., Englund M; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg 431 83, Sweden., Uggla T; Laboratory Animal Sciences, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg 431 83, Sweden., Antonsson M; Laboratory Animal Sciences, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg 431 83, Sweden., Nunes F; Laboratory Animal Sciences, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg 431 83, Sweden., Hilgendorf C; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg 431 83, Sweden., Bergström CAS; The Swedish Drug Delivery Center, Department of Pharmacy, Uppsala University, Uppsala 751 23, Sweden., Davies N; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg 431 83, Sweden.
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2024 Jan 01; Vol. 21 (1), pp. 313-324. Date of Electronic Publication: 2023 Dec 06.
Autor:
Berg S; The Swedish Drug Delivery Center, Department of Pharmacy, Uppsala University, BMC P.O. Box 580, Uppsala SE-751 23, Sweden.; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg 431 83, Sweden., Suljovic D; The Swedish Drug Delivery Center, Department of Pharmacy, Uppsala University, BMC P.O. Box 580, Uppsala SE-751 23, Sweden., Kärrberg L; Animal Sciences and Technologies, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg 431 83, Sweden., Englund M; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg 431 83, Sweden., Bönisch H; Affibody AB, Solna 171 65, Sweden., Karlberg I; Affibody AB, Solna 171 65, Sweden., Van Zuydam N; Data Science and Quantitative Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg 431 83, Sweden., Abrahamsson B; Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg 431 83, Sweden., Hugerth AM; Ferring Pharmaceuticals A/S, Product Development and Drug Delivery, Global Pharmaceutical R&D, Amager Strandvej 405, Kastrup 2770, Denmark., Davies N; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg 431 83, Sweden., Bergström CAS; The Swedish Drug Delivery Center, Department of Pharmacy, Uppsala University, BMC P.O. Box 580, Uppsala SE-751 23, Sweden.
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2022 Jul 04; Vol. 19 (7), pp. 2564-2572. Date of Electronic Publication: 2022 Jun 01.
Autor:
Berg S; The Swedish Drug Delivery Center, Department of Pharmacy, Uppsala University, BMC P.O. Box 580, SE-751 23 Uppsala, Sweden.; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, 431 83 Gothenburg, Sweden., Kärrberg L; Animal Sciences and Technologies, Clinical Pharmacology and Safety Sciences, Biopharmaceuticals R&D, AstraZeneca, 431 83 Gothenburg, Sweden., Suljovic D; The Swedish Drug Delivery Center, Department of Pharmacy, Uppsala University, BMC P.O. Box 580, SE-751 23 Uppsala, Sweden., Seeliger F; Cardiovascular, Renal and Metabolism Safety, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, 431 83 Gothenburg, Sweden., Söderberg M; Cardiovascular, Renal and Metabolism Safety, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, 431 83 Gothenburg, Sweden., Perez-Alcazar M; Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, Biopharmaceuticals R&D, AstraZeneca, 431 83 Gothenburg, Sweden., Van Zuydam N; Data Science and Quantitative Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, 431 83 Gothenburg, Sweden., Abrahamsson B; Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, 431 83 Gothenburg, Sweden., Hugerth AM; Ferring Pharmaceuticals A/S Global Pharmaceutical R&D, 2300 Copenhagen, Denmark., Davies N; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, 431 83 Gothenburg, Sweden., Bergström CAS; The Swedish Drug Delivery Center, Department of Pharmacy, Uppsala University, BMC P.O. Box 580, SE-751 23 Uppsala, Sweden.
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2022 Jan 03; Vol. 19 (1), pp. 200-212. Date of Electronic Publication: 2021 Dec 20.
Autor:
Vinarov Z; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium; Department of Chemical and Pharmaceutical Engineering, Sofia University, Sofia, Bulgaria., Abrahamsson B; Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, Sweden., Artursson P; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Batchelor H; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom., Berben P; Pharmaceutical Development, UCB Pharma SA, Braine- l'Alleud, Belgium., Bernkop-Schnürch A; Department of Pharmaceutical Technology, Institute of Pharmacy, University of Innsbruck, Innsbruck, Austria., Butler J; GlaxoSmithKline Research and Development, Ware, United Kingdom., Ceulemans J; Janssen Pharmaceutica NV, Beerse, Belgium., Davies N; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg, Sweden., Dupont D; INRAE, Institut Agro, STLO, Rennes, France., Flaten GE; Department of Pharmacy, UiT The Arctic University of Norway, Tromsø, Norway., Fotaki N; Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom., Griffin BT; School of Pharmacy, University College Cork, Cork, Ireland., Jannin V; Lonza Pharma & Biotech, Colmar, France., Keemink J; Janssen Pharmaceutica NV, Beerse, Belgium., Kesisoglou F; Pharmaceutical Sciences, Merck & Co. Inc., Rahway, NJ, USA., Koziolek M; Abbvie Deutschland GmbH & Co. KG, Ludwigshafen, Germany., Kuentz M; Institute for Pharma Technology, University of Applied Sciences and Arts Northwestern Switzerland, Basel, Switzerland., Mackie A; School of Food Science & Nutrition, University of Leeds, Leeds, United Kingdom., Meléndez-Martínez AJ; Food Colour & Quality Laboratory, Area of Nutrition & Food Science, Universidad de Sevilla, Seville, Spain., McAllister M; Drug Product Design, Pfizer PGRD, Sandwich, United Kingdom., Müllertz A; Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark., O'Driscoll CM; School of Pharmacy, University College Cork, Cork, Ireland., Parrott N; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Paszkowska J; Physiolution Polska Sp. Z o.o., Wroclaw, Poland., Pavek P; Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic., Porter CJH; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia., Reppas C; Department of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece., Stillhart C; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Sugano K; College of Pharmaceutical Sciences, Ritsumeikan University, Shiga, Japan., Toader E; Faculty of Medicine, University of Medicine and Pharmacy of Iasi, Romania., Valentová K; Institute of Microbiology of the Czech Academy of Sciences, Prague, Czech Republic., Vertzoni M; Department of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece., De Wildt SN; Department of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, the Netherlands., Wilson CG; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom., Augustijns P; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium. Electronic address: patrick.augustijns@kuleuven.be.
Publikováno v:
Advanced drug delivery reviews [Adv Drug Deliv Rev] 2021 Apr; Vol. 171, pp. 289-331. Date of Electronic Publication: 2021 Feb 18.
Autor:
Davies NM; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada., Wright MR, Russell AS, Jamali F
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 1996 Nov; Vol. 85 (11), pp. 1170-3.
Autor:
Davies NT
Publikováno v:
The British journal of nutrition [Br J Nutr] 1980 Jan; Vol. 43 (1), pp. 189-203.
Publikováno v:
Ciba Foundation symposium [Ciba Found Symp] 1979 Jan 16-18 (70), pp. 247-66.
Autor:
Davies NT, Campbell JK
Publikováno v:
Life sciences [Life Sci] 1977 Mar 15; Vol. 20 (6), pp. 955-60.
Autor:
Davies NT, Nightingale R
Publikováno v:
The British journal of nutrition [Br J Nutr] 1975 Sep; Vol. 34 (2), pp. 243-58.